Nykredit A/S’s Dr. Reddy's Laboratories RDY Stock Holding History

Nykredit A/S’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2M	Buy	+137,993	New	+$1.86M	0.01%	605

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Nykredit A/S's RDY Position: Q2 2026 in Review

Nykredit A/S opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 137,993 shares worth $2M. The stake represents 0.01% of the portfolio and ranks #605 among its holdings.

194 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Nykredit A/S held 137,993 shares of Dr. Reddy's Laboratories worth $2M as of Q2 2026.
Dr. Reddy's Laboratories was a new Nykredit A/S position in Q2 2026.
Dr. Reddy's Laboratories made up 0.01% of Nykredit A/S's portfolio in Q2 2026, its #605 holding.
194 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.